Pharma Stocks
-
Sensex, Nifty gap up on Iran diplomacy, crude slide; financials lead, pharma drags
Benchmarks opened sharply higher on Monday, August 3, 2026, as easing geopolitical tensions in West Asia and a fall in…
Read More » -
MOFSL stays bullish on Sun Pharma; sees 16% upside on innovation pipeline
ET Intelligence Group: Sun Pharma‘s June quarter performance was broadly in line with analysts’ expectations. Expanding specialty and innovative medicines…
Read More » -
Amneal (AMRX) Stock Looks Fairly Valued Following Raised 2026 Guidance
Amneal Pharmaceuticals stock has delivered a very strong 345.7% return over the past 3 years, yet its valuation checks lean…
Read More » -
We’re Keeping An Eye On Cloudbreak Pharma’s (HKG:2592) Cash Burn Rate
Even when a business is losing money, it’s possible for shareholders to make money if they buy a good business…
Read More » -
Sun Pharma withdraws multiple eye drop products as precautionary measure
Sun Pharma has initiated a precautionary withdrawal of several eye drop products and instructed distributors to stop billing and return…
Read More » -
NewAmsterdam Pharma (NAMS) On EU Backing Is The Pullback Leaving Shares Mispriced
NewAmsterdam Pharma (NAMS) is back in focus after regulators in Europe issued a positive opinion on Ubeslo and Evlarco, two…
Read More » -
Why AbbVie Stock Slumped Today
Key Points It posted a second-quarter earnings report that raised some concerns. One was a miss on the consensus bottom-line…
Read More » -
Phathom Pharmaceuticals (PHAT) Stock Slides Despite Cash Profit Breakthrough
Phathom Pharmaceuticals came into this earnings print with a bruised stock chart, down double digits over the past month and…
Read More » -
Glenmark Pharma Q1 profit jumps over 10-fold as India, North America businesses power growth
Pharma major Glenmark Pharmaceuticals Ltd on Friday (July 31) reported a 930% year-on-year increase in consolidated net profit to ₹483…
Read More » -
Amgen Stock Leads 3 Cardiovascular Pharma Picks After Novo Nordisk Trial Miss
A failed late stage heart drug trial at Novo Nordisk, with shares in Copenhagen down 8.6% and U.S. ADRs down…
Read More »